Probi’s Financial Calendar 2019 and new reporting date for the Q3 report 2018
Probi informs that the Financial Calendar 2019 has been published on the company´s website, www.probi.com, under the investor relations section.
Probi also decided to update the Financial Calendar of the current year and publish its Q3 report on Thursday November 1st, 2018 at 8:00 a.m. CET. The change from the previously announced reporting date, November 6th, 2018, is due to administrative reasons.
Reporting dates for 2018 / 2019:
1 November 2018 - Interim Report Q3 2018
13 February 2019 - Year-end Report 2018
29 April 2019 - Interim Report Q1 2019
7 May 2019 - Annual General Meeting 2018
25 July 2019 - Interim Report Q2 2019
28 October 2019 - Interim Report Q3 2019
11 February 2020 - Year-end Report 2019
FOR FURTHER INFORMATION, CONTACT:
Jörn Andreas, CFO, tel +46 46 286 89 41, e-mail: jorn.andreas@probi.com
Niklas Brandt, Investor Relations, tel +46 46 286 89 26, e-mail: niklas.brandt@probi.com
ABOUT PROBI
Probi AB is a Swedish publicly traded bioengineering company. The vision of Probi is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Founded by scientists in Sweden in 1991, Probi is a multinational company with four sites, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2017, Probi had net sales of MSEK 612. The Probi share is listed on Nasdaq Stockholm, Mid Cap. Probi has about 5,000 shareholders. Read more at www.probi.com.
Tags: